Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam vs Sodium Valproate in Pediatric Refractory Status Epilepticus
NCT02920060Phase 2Completed
- Sponsor
- Banaras Hindu University
- Start
- Jan 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of levetiracetam in generalized convulsive status epilepticus (GCSE), sponsored by Banaras Hindu University. Primary endpoint: Cessation of convulsions at 30 months. Started Jan 2015; status: completed.
02
Drugs
levetiracetam
03
Conditions
generalized convulsive status epilepticus (GCSE)
Beyond the preview
Go deeper on NCT02920060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02920060.